The Development and Program Management team at Tectonic Therapeutic is responsible for orchestrating the strategic planning, development, and clinical progression of antibody and biologic drug candidates targeting G-protein Coupled Receptors (GPCRs). This team ensures cohesive project execution, oversees regulatory compliance, and drives the transition of therapies from preclinical stages through to clinical trials.
Alise Reicin
President & CEO & Director
Anthony (Tony) Musli...
Chief Development Officer
Anthony Muslin
Chief Development Officer
Jaime Darce
Senior Director, Pharmacology
Joseph Toth
Director
Kathryn Bracken
Associate Vice President, Prog...
Mary E. West, MS
Svp, Clinical Development Oper...
Praveen Tipirneni
Director
Stefan Vitorovic
Director
Timothy A. Springer
Co-Founder & Director
View all